Industry committee  There's been speculation that it's price negotiations, etc., but we don't know that. What we can clearly say, and we have all the dates documented and have submitted the documentation to the Senate committee, is that it took 68 days of CAMR. All the delays, whatever the causes we

Industry committee  Just very briefly, what we said was that we are voluntarily collaborating internationally, and absolutely with generics, and that has proven to be far more effective. That partnership is the solution, but it's voluntary. We're very proud of the donations we make and we've made th

Industry committee  Absolutely. I think some of the criticisms about CAMR would be a little more credible if there had been a second application, or a third application, and it hadn't worked. At least Apotex moved forward on the first one, and that should be duly noted. Where has everybody else been

Industry committee  Can I jump in here, Mr. Masse, if it's all right?

Industry committee  This presumes that IP is a barrier and you're presuming that weakening IP in this country is going to facilitate access to medicines. I don't believe that. I think what we have to work very carefully on here is that unintended consequences could be quite serious. I identified som

Industry committee  I think you have seen already, in the one example that's been effective, that when there were terminations of time schedules, the three companies involved on our side voluntarily extended them and supported the principles of CAMR. That was a non-issue. It seems to me that the che

Industry committee  Then why haven't more people come forward?

Industry committee  It worked.

Industry committee  When the rules were followed it worked.

Industry committee  But when the rules were followed it worked in 60 days. Thank you.

Industry committee  I'm perplexed that they're holding off. I am very perplexed. The generic companies are sitting back and telling Canada that unless parliamentarians change this law, they will not use it again. I find that kind of positioning, when we're talking about this kind of humanitarian cau

Industry committee  Mr. Bouchard, I can get you copies of documents issued by the Access to Medicine Foundation, which conducted an assessment of global trends. To answer your question, we began using our generic medicines through more voluntary and more creative measures. We could provide you with

Industry committee  I think that all committee members could simply get in touch with generic medicine companies, encourage them to use the regime and discuss voluntary measures with them. That way, we could move forward together and find much more creative solutions. I don't think that amending the

Finance committee  Thank you very much for the opportunity to present for Rx&D, Canada's Research-Based Pharmaceutical Companies, which represent about 50 research-based companies, with well over 15,000 men and women involved in high-level research in Canada. We create, deliver, and research n

Finance committee  We're still going through it, but it goes in a pretty good direction. Frankly, I think they've highlighted a lot of what we know and it's now time for action. If I can use the time of the answer, I would call this a very urgent issue. It's time to take some of those recommendat